[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-356054-105":3,"doc-detail-356054-en":81,"detail-sidebar-cat-0-en-105":116},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","transcriptomic-and-epigenomic-insights-into-ovarian-cancer-a-bioinformatics-perspective-a-narrative-review","Transcriptomic and epigenomic insights into ovarian cancer: a bioinformatics perspective - a narrative review","","Ovarian cancer is a highly heterogeneous malignancy with complex molecular underpinnings that extend beyond genomic mutations to include transcriptomic and epigenomic alterations. Next-generation sequencing and bioinformatics enable comprehensive profiling of gene expression, non-coding RNAs, DNA methylation, histone modifications, and chromatin accessibility. Transcriptomic and epigenomic integration identifies regulatory networks and molecular subtypes, supporting better understanding of heterogeneity and progression. Bioinformatics enables differential expression, epigenetic mapping, and multi-omics integration to reveal biomarkers, therapeutic targets, mechanisms of chemoresistance and immune evasion, and avenues for personalized therapy and improved patient stratification.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/transcriptomic-and-epigenomic-insights-into-ovarian-cancer-a-bioinformatics-perspective-a-narrative-review/356054/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/transcriptomic-and-epigenomic-insights-into-ovarian-cancer-a-bioinformatics-perspective-a-narrative-review/356054.png","ImageObject",300,407,{"name":42,"@type":43},"kopisore","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-28","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",9,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Why are transcriptomic and epigenomic changes important for ovarian cancer biology?","Question",{"text":63,"@type":64},"Transcriptomic and epigenomic alterations shape regulatory networks that underlie tumor initiation, progression, and therapeutic resistance. Together, they provide insights beyond static DNA mutation profiles.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Which types of molecular data are emphasized in the review?",{"text":68,"@type":64},"The review highlights gene expression patterns, non-coding RNAs, DNA methylation, histone modifications, and chromatin accessibility, enabled by next-generation sequencing and bioinformatics.",{"name":70,"@type":61,"acceptedAnswer":71},"How can bioinformatics contribute to identifying biomarkers and therapeutic targets?",{"text":72,"@type":64},"Bioinformatics pipelines support differential expression analysis, epigenetic mapping, and multi-omics integration. These analyses help identify key regulatory networks, molecular subtypes, potential biomarkers, and therapeutic targets, including pathways related to chemoresistance and immune evasion.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},356054,1790186557,{"code":4,"msg":82,"data":83},"success",{"doc_id":79,"user_id":84,"nickname":42,"user_avatar":85,"doc_module":4,"category_id":86,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":87,"file_id":88,"file_url":89,"file_type":90,"file_size":91,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":92,"language":93,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":94,"faqs":95,"seo_title":96,"seo_description":12,"update_tm":97,"read_time":98,"preview_page_count":33,"preview_urls":99},962090880963,"https://ap-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8",8,"Review  \nTranscriptomic and epigenomic insights into ovarian cancer: a bioinformatics perspective – a narrative review  \nEmmanuel Ifeanyi Obeagu, PhDa,b ,*  \nAbstract  \nOvarian cancer is a highly heterogeneous malignancy with complex molecular underpinnings that extend beyond genomic  \nmutations to encompass transcriptomic and epigenomic alterations. Advances in next-generation sequencing and bioinformatics have enabled comprehensive profiling of gene expression patterns, non-coding RNAs, DNA methylation, histone modifications, and chromatin accessibility, offering novel insights into ovarian tumor biology. Transcriptomic analyses reveal dysregulated coding and non-coding RNA networks, while epigenomic studies uncover epigenetic modifications that regulate gene expression and chromatin structure, together shaping the cancer phenotype. The integration of transcriptomic and epigenomic data through sophisticated bioinformatics pipelines allows the identification of key regulatory networks and molecular subtypes, enhancing our understanding of ovarian cancer heterogeneity and progression. Bioinformatics tools facilitate differential expression analysis, epigenetic mapping, and multi-omics data integration, revealing potential biomarkers and therapeutic targets. These approaches have also illuminated mechanisms of chemoresistance and immune evasion, providing avenues for personalized therapy and improved patient stratification. Datasets will be critical to harness the full potential of transcriptomic and epigenomic research. Ultimately, bioinformatics-driven insights into the ovarian cancer transcriptome and epigenome promise to inform early diagnosis, prognostication, and the development of targeted therapies, advancing precision oncology in this lethal  \nKeywords: bioinformatics, epigenomics, molecular biomarkers, ovarian cancer, transcriptomics  \nIntroduction  \nOvarian cancer remains one of the most lethal gynecological malignancies worldwide, largely due to its asymptomatic nature in early stages and the resulting late diagnosis. Despite advancesin surgical techniques and chemotherapy, the overall survival rate for ovarian cancer patients has remained disappointingly low. This poor prognosis is partly attributed to the complex molecular heterogeneity of ovarian tumors, which poses significant challenges for early detection, treatment, and prognosis. Traditional genomic analyses focusing on somatic mutations and copy number variations have provided important insights but fail to capture the full spectrum of molecular alterations driving ovarian cancer. As such, there is a growing recognition  \naDivision of Haematology, Department of Biomedical and Laboratory Science, Africa University, Muatre, Zimbabwe and bDepartment of Molecular Medicine and Haematology, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa  \nSponsorships or competing interests that may be relevant to content are disclosed at the end of this article.  \n*Corresponding author. Address: Department ofBiomedical and Laboratory Science, Africa University, Mutare, Zimbabwe. Tel.: +2348037369912.  \n[E-mail: emmanuelobeagu@yahoo.com](E-mail: emmanuelobeagu@yahoo.com) (E. I. Obeagu).  \nCopyright © 2026 The Author(s). Published by Wolters Kluwer Health, Inc. This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.  \nAnnals of Medicine & Surgery (2026) 88:5073–5079  \nReceived 14 September 2025; Accepted 14 January 2026  \nPublished online 20 February 2026  \n[http://dx.doi.org/10.1097/MS9.0000000000004798](http://dx.doi.org/10.1097/MS9.0000000000004798)  \nHIGHLIGHTS  \n● Integrates transcriptomic and epigenomic data to unravel ovarian cancer mechanisms.  \n● Highlights bioinformatics tools for molecular profiling.  \n● Identifies biomarkers for prognosis.  ","cbCaidmAXJAHLQH7","https://ap.wps.com/l/cbCaidmAXJAHLQH7","pdf",265006,7,"English","# Abstract\n# Keywords\n# Introduction\n# HIGHLIGHTS\n## Transcriptomics\n## Epigenomics","[{\"question\":\"Why are transcriptomic and epigenomic changes important for ovarian cancer biology?\",\"answer\":\"Transcriptomic and epigenomic alterations shape regulatory networks that underlie tumor initiation, progression, and therapeutic resistance. Together, they provide insights beyond static DNA mutation profiles.\"},{\"question\":\"Which types of molecular data are emphasized in the review?\",\"answer\":\"The review highlights gene expression patterns, non-coding RNAs, DNA methylation, histone modifications, and chromatin accessibility, enabled by next-generation sequencing and bioinformatics.\"},{\"question\":\"How can bioinformatics contribute to identifying biomarkers and therapeutic targets?\",\"answer\":\"Bioinformatics pipelines support differential expression analysis, epigenetic mapping, and multi-omics integration. These analyses help identify key regulatory networks, molecular subtypes, potential biomarkers, and therapeutic targets, including pathways related to chemoresistance and immune evasion.\"}]","Transcriptomic and epigenomic insights into ovarian cancer: a bioinformatics perspective - a narrative review | PDF",1790123062,18,[100,104,108,112],{"page_no":22,"url":101,"width":102,"height":103},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7ab6eb45b180cccc5af57b5fe22a3672.webp",983,1310,{"page_no":26,"url":105,"width":106,"height":107},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b0d1f3e600b6949f3453ac2c724789a8.webp",982,1309,{"page_no":30,"url":109,"width":110,"height":111},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/37fdfbb8dc289933fff9f25f84126a47.webp",981,1308,{"page_no":33,"url":113,"width":114,"height":115},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5e996472306f24b167069a252a974cc5.webp",980,1306,{"code":4,"msg":82,"data":117},[118,122,126,130,135,140,144,147,151,154,158],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":119,"show_sort_weight":120,"slug":121},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":123,"show_sort_weight":124,"slug":125},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":127,"show_sort_weight":128,"slug":129},"Exam",70,"exam",{"id":131,"doc_module":4,"doc_module_name":25,"category_name":132,"show_sort_weight":133,"slug":134},5,"Comic",60,"comic",{"id":136,"doc_module":4,"doc_module_name":25,"category_name":137,"show_sort_weight":138,"slug":139},6,"Technology",50,"technology",{"id":92,"doc_module":4,"doc_module_name":25,"category_name":141,"show_sort_weight":142,"slug":143},"Healthcare",40,"healthcare",{"id":86,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":145,"slug":146},30,"research-report",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":148,"show_sort_weight":149,"slug":150},"Religion & Spirituality",20,"religion-spirituality",{"id":149,"doc_module":4,"doc_module_name":25,"category_name":152,"show_sort_weight":149,"slug":153},"World Cup","world-cup",{"id":155,"doc_module":4,"doc_module_name":25,"category_name":156,"show_sort_weight":155,"slug":157},10,"Lifestyle","lifestyle",{"id":159,"doc_module":4,"doc_module_name":25,"category_name":160,"show_sort_weight":131,"slug":161},19,"General","general"]